# Tryptase and Coronary Heart Disease

> **NCT01618279** · — · COMPLETED · sponsor: **Niguarda Hospital** · enrollment: 350 (actual)

## Conditions studied

- Acute Coronary Syndrome With ST Elevation on Electrocardiogram
- Acute Coronary Syndrome Without ST Elevation on Electrocardiogram
- Noncritical Coronary Artery Disease Coronary Stenosis Less Than 50 Per Cent
- Aortic Aneurysms

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT01618279
- **Lead sponsor:** Niguarda Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2013-01
- **Primary completion:** 2021-12
- **Final completion:** 2022-01
- **Target enrollment:** 350 (ACTUAL)
- **Last updated:** 2022-01-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01618279

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01618279, "Tryptase and Coronary Heart Disease". Retrieved via AI Analytics 2026-08-11 from https://api.ai-analytics.org/clinical/NCT01618279. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*